Home workouts before transplant may boost strength in myeloma patients
NCT ID NCT05706766
First seen Jun 27, 2026 ยท Last updated Jun 27, 2026
Summary
This study tests whether an 8-week home-based exercise program, done before a stem cell transplant, can improve muscle strength and physical fitness in people with multiple myeloma. Thirty participants will either exercise via Zoom or continue normal activities. The goal is to see if prehabilitation helps patients feel stronger and recover more smoothly after transplant.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- Active substance
- Prehabilitation aerobic and resistance exercise program
- What this could lead to
- If it works, this could show that a simple home exercise program before transplant helps patients feel stronger and recover faster.
- What could go wrong
- This is a small early trial with only 30 participants, so results may not apply to everyone. Exercise may not improve outcomes for all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Dana Farber Cancer Institute
RECRUITINGBoston, Massachusetts, 02215, United States
-
Dana-Farber Cancer Institute
RECRUITINGBoston, Massachusetts, 02215, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could muscle loss predict blood cancer outcomes?
- Can a Triple-Action antibody deepen remissions in myeloma?
- Can a Low-Dose antifungal shield vulnerable patients from deadly fungal infections?
- Can a gentler chemo prep make stem cell transplants safer for blood cancer patients?
- Talking about the end: could guided conversations reduce futile cancer treatments?
- A guided path back to work after blood cancer: a trial tests the impact